Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTATP6P8, named as MT-ATP6 pseudogene 8, is a pseudogene annotation based on sequence similarity to the functional MT-ATP6 gene. MT-ATP6 encodes subunit 6 of the mitochondrial ATP synthase complex involved in cellular energy generation[1][4][5]. In contrast, MTATP6P8/MT-ATP6 pseudogene 8 does not encode a functional protein and does not participate in mitochondrial oxidative phosphorylation. Pseudogenes like MTATP6P8 generally arise from gene duplication or retrotransposition events and accumulate mutations that inactivate their protein-coding potential; some may have regulatory functions, but MTATP6P8 specifically is not known to have any functional role or disease association. It is not a receptor, enzyme, transporter, or therapeutically relevant molecule. For reference, MT-ATP6 (not MTATP6P8) is a critical mitochondrial gene encoding ATP synthase subunit 6; mutations in MT-ATP6 cause diseases such as Leigh syndrome and NARP[1][3][4][5]. MTATP6P8 is just a sequence remnant with no known function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ATP6 pseudogene 8 (MTATP6P8).